Revenue, 2024 (US$M)
$0.0
Forecast, 2030 (US$M)
$990.7
CAGR, 2025 - 2030
-100%
Report Coverage
Worldwide

Global herpes simplex virus treatment market, 2018-2030 (US$M)

Related Markets

Global herpes simplex virus treatment market highlights

  • The global herpes simplex virus treatment market generated a revenue of USD 9,875.9 million in 2023 and is expected to reach USD 12,376.4 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 3.3% by 2030.
  • In terms of segment, drug accounted for a revenue of USD 2,469.0 million in 2023.
  • Type is the most lucrative therapeutics segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Japan is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 9,875.9 million
Market revenue in 2030USD 12,376.4 million
Growth rate3.3% (CAGR from 2023 to 2030)
Largest segmentDrug
Fastest growing segmentType
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationType, Drug, Distribution Channel, Route of Administration

Other key industry trends

  • In terms of revenue, the North America accounted for 32.3% of the global herpes simplex virus treatment market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Japan is the fastest growing regional market and is projected to reach USD 436.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Herpes Simplex Virus Treatment Market Scope

Herpes simplex virus treatment market segmentation & scope
Type
Herpes Simplex Virus 1
Herpes Simplex Virus 2
Drug
Acyclovir
Valacyclovir
Famciclovir
Other Drug
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Route of Administration
Oral
Injectable
Topical

Herpes Simplex Virus Treatment Market Companies

Name Profile # Employees HQ Website

Global herpes simplex virus treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to herpes simplex virus treatment market will help companies and investors design strategic landscapes.


Drug was the largest segment with a revenue share of 25% in 2024. Horizon Databook has segmented the Global herpes simplex virus treatment market based on type, drug, distribution channel, route of administration covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Herpes Simplex Virus Treatment Type Outlook (Revenue, USD Million, 2018-2030)
    • Herpes Simplex Virus 1
    • Herpes Simplex Virus 2
  • Global Herpes Simplex Virus Treatment Drug Outlook (Revenue, USD Million, 2018-2030)
    • Acyclovir
    • Valacyclovir
    • Famciclovir
    • Other Drug
  • Global Herpes Simplex Virus Treatment Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Herpes Simplex Virus Treatment Route of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Oral
    • Injectable
    • Topical

Reasons to subscribe to Global herpes simplex virus treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global herpes simplex virus treatment market databook

  • Our clientele includes a mix of herpes simplex virus treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global herpes simplex virus treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global herpes simplex virus treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global herpes simplex virus treatment size, by regions, 2018-2030 (US$M)

Top 10 countries: Herpes simplex virus treatment size, 2023 (US$M)

Global herpes simplex virus treatment share, by therapeutics, 2023 & 2030 (%, US$M)

Herpes simplex virus treatment market: Opportunity assessment by country

Global herpes simplex virus treatment market, by region, 2024 (US$M)

Global herpes simplex virus treatment size, by regions, 2018-2030 (US$M)

Therapeutics 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR
North America 2,666.2 2,772.9 2,799.0 2,932.0 3,079.2 3,194.4 3,309.0 3,423.6 3,537.8 3,651.3 3,763.9 3,875.3 3,985.1 3.2%
Europe 2,320.3 2,415.3 2,440.2 2,558.3 2,689.1 2,792.1 2,894.8 2,997.5 3,100.2 3,202.5 3,304.1 3,404.8 3,504.3 3.3%
Asia Pacific 1,385.2 1,440.7 1,454.4 1,523.6 1,600.2 1,660.1 1,719.8 1,779.4 1,838.9 1,898.0 1,956.6 2,014.6 2,071.8 3.2%
Latin America 619.5 645.0 651.9 683.6 718.8 746.6 774.3 802.1 829.8 857.4 884.9 912.2 939.1 3.3%
MEA 1,224.8 1,276.4 1,291.1 1,355.2 1,426.2 1,482.6 1,538.9 1,595.4 1,652.0 1,708.5 1,764.8 1,820.7 1,876.2 3.4%
Overall 8,215.9 8,550.2 8,636.6 9,052.6 9,513.4 9,875.9 10,236.8 10,598.0 10,958.6 11,317.7 11,674.4 12,027.6 12,376.4 3.3%

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more